- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Thyroid Disorders
The Endocrinology Network® Thyroid Disorders clinical resource center offers readers insight and perspective into the latest from management of hypothyroidism, hyperthyroidism, thyroid cancers, and other thyroid disorders. One of the most common disorders seen by endocrinologists and those practicing in endocrinology, our thyroid disorders resource center hosts content related to FDA approvals, the latest studies, and guideline updates in management of thyroid disorders.
Nearly 1-in-3 of Physicians Could Be Overusing Thyroid Ultrasonography
August 14, 2020
A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.
Risk of Solid Cancer Death Not Influenced by Hyperthyroidism Treatment
July 24, 2020
New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.
Levothyroxine Fails to Provide Cardiac Benefit in Subclinical Hypothyroidism
July 21, 2020
New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.
Study Reports First Known Case of Subacute Thyroiditis After COVID-19 Infection
May 21, 2020
A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.
L-Thyroxine Ineffective In Patients With Subclinical Hypothyroidism, Study Says
May 04, 2020
The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.
VIDEO: Teprotumumab Offers Hope for Thyroid Eye Disease Patients
April 14, 2020
New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.
First Treatment for Thyroid Eye Disease Approved by FDA
January 22, 2020
The FDA announced yesterday that it has approved the first treatment for thyroid eye disease: teprotumumab-trbw (Tepezza, Horizon Therapeutics).
Thyroid Treatment Can Aid in Adaption to Cold Environments
May 22, 2019
Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.
New Analysis Says No Need to Treat Subclinical Hypothyroidism
May 22, 2019
Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.
Treatment Recommendations for Cardiovascular Conditions with Thyroid Dysfunction
May 15, 2019
Thyroid hormones have a wide range of effects of the cardiovascular system. Too much or too little thyroiid hormones can induce or exacerbate existing cardiovascular disorders. In this article, we highlight the treatment recommendations for thyroid-related CVD events.